Therapeutic Effects of Salvianolic Acid B on Angiotensin II-Induced Atrial Fibrosis by Regulating Atrium Metabolism via Targeting AMPK/FoxO1/miR-148a-3p Axis.
Therapeutic Effects of Salvianolic Acid B on Angiotensin II-Induced Atrial Fibrosis by Regulating Atrium Metabolism via Targeting AMPK/FoxO1/miR-148a-3p Axis.
复制标题
丹酚酸 B 通过靶向 AMPK/FoxO1/miR-148a-3p 轴调节心房代谢对血管紧张素 II 诱导的心房纤维化的治疗作用
DOI:
10.1007/s12265-022-10303-3
复制
发表时间:
2023-04
影响因子:
3.4
通讯作者:
Zhang, Daoliang
中科院分区:
文献类型:
--
作者:
Liu, Jie;Sun, Qijuan;Sun, Xiaotong;Wang, Qian;Zou, Guangchen;Wang, Dewei;Zhuang, Baoxiang;Juan, Zhaodong;Zhang, Rui;Zhang, Daoliang
The present study highlights the effects of salvianolic acid B (Sal B) on angiotensin II (Ang II)–activated atrial fibroblasts as well as the associated potential mechanism from the metabonomics perspective. Metabolic profile analysis performed an optimal separation of the Ang II and control group, indicating a recovery impact of Sal B on Ang II–activated fibroblasts (FBs). We found that metabolite levels in the Ang II + Sal B group were reversed to normal. Moreover, 23 significant metabolites were identified. Metabolic network analysis indicated that these metabolites participated in purine metabolism and FoxO signaling pathway. We found that Sal B activated AMP-activated protein kinase (AMPK) phosphorylation, which further promoted FoxO1 activation and increased miR-148a-3p level. We further verified that Sal B modulate the abnormal AMP, phosphocreatine, glutathione (GSH), and reactive oxygen species (ROS) production in Ang II–stimulated FBs. Collectively, Sal B can protect the Ang II–activated FBs from fibrosis and oxidative stress via AMPK/FoxO1/miRNA-148a-3p axis.
登录
查看更多内容
影响因子:
4.6
作者:
Liu Q;Chu H;Ma Y;Wu T;Qian F;Ren X;Tu W;Zhou X;Jin L;Wu W;Wang J
通讯作者:
Wang J
影响因子:
--
作者:
Ma B;Liu Y;Zhang X;Zhang R;Zhang Z;Zhang Z;Liu J;Juan Z;Sun X;Sun L;Huang J;Feng J
通讯作者:
Feng J
影响因子:
--
作者:
Fu L;Xu Y;Tu L;Huang H;Zhang Y;Chen Y;Tao L;Shen X
通讯作者:
Shen X
影响因子:
39.3
作者:
Fragasso, G;Perseghin, G;Margonato, A
通讯作者:
Margonato, A
影响因子:
16.1
作者:
Higashi T;Friedman SL;Hoshida Y
通讯作者:
Hoshida Y